Theranano LLC

Theranano was founded to translate nanomedicines from the lab to the clinic. Theranano LLC has a strong pipeline of technologies based on discoveries in nanomedicines and medical imaging made in Professor Srinivas Sridhar’s laboratory at Northeastern University. The InCeRT platform for sustained delivery of chemotherapeutics is currently being scaled up for GMP and an IND filing is underway. We anticipate clinical trials on prostate cancer in 2021 in collaboration with Dana Farber Cancer Institute. A quantitative MRI method called QUTE-CE MRI uses magnetic nanoparticles to obtain vascular images with unprecedented clarity and definition, and is currently being tested in clinical trials for human brain imaging at Massachusetts General Hospital with funding from NIH. Nanoformulations of PARP and other inhibitors for cancer therapy are currently being tested in pre-clinical studies.